| 查看: 871 | 回复: 20 | |||
[交流]
杂志征稿:Special Issue 精准个性化医疗
|
|||
|
Biomedical Informatics Insights 是PubMed检索,special issue稿费有discount,而且还有几个免稿费名额,欢迎投稿。 https://insights.sagepub.com/la_ ... p;news_item_id=4112 Biomedical Informatics Insights Special Issue on Precision and Individualized Medicine Summary and Scope In 2015 President Obama has announced a research initiative that aims to accelerate progress toward a new era of precision medicine. The aim of precision medicine is to develop innovative prevention and treatment strategies that take individual variability into account. Recent development of large-scale genome sequence data and computational tools for analyzing large sets of data has made the prospect of applying this concept dramatically improved. Emerging evidence suggests that health practitioners can utilize patients’ genomic data to improve individualized care in clinical practice. For example, there is a rapidly growing expectation to incorporate genomic medicine into individualized patient care. Despite the numerous benefits, the challenges to integrate genomics into patient care are vast. In addition, it is still a mystery how to take advantage of rich data through clinical trials, electronic medical records, and other means. This Special Collection will gather all studies related to approaches to utilizing trait (genetic) and state (clinical) data in practice. Submissions are invited to address the need for developing innovative methods that can potentially lead to significant advances in the precision and individualized medicine. Topics of Interest The topics of interest include but are not limited to: • Practical applications of genomics for individualizing patient care • Applications for integrating genomics and pharmacogenomics to clinical practice • Strategies to overcome obstacles with implementing genomic medicine • Genomic technology applications, impact on health care delivery, and implications for patients and medical professionals • Predictive and prognostic genomic discoveries which impact the understanding of health and disease • Big data analysis including machine learning and data mining applications on genetics and clinical data • Research and discoveries in precision and individualized medicine Submission Guidelines Before submitting your manuscript, please ensure you have carefully read the Author Guidelines and Submission Guidelines. The complete manuscript should be submitted through Biomedical Informatics Insights Submission System. Submission Deadlines Abstract Submission Due: Dec 30, 2017 (abstracts are required, please email to: bii.precisionmedicine@gmail.com) Response: Jan 10, 2017 Paper Submission Due: Jan 30, 2017 (submit to: http://insights.sagepub.com/submit_step_1.php) First Review Notification: Feb 28, 2018 Revision Due: Mar 30, 2018 Final Notification: Apr 15, 2018 |
» 猜你喜欢
公派留学必须选世界排名前一百的学校吗?
已经有10人回复
CSC中了的话可以去公司进行短期实习吗?
已经有5人回复
中药学论文润色/翻译怎么收费?
已经有142人回复
预计12点公布
已经有16人回复
拿下了青年基金 未来三年拿下面上!
已经有103人回复
直博是否为好的选择
已经有9人回复
任职高校没有硕博学位点,是否应考虑跳槽?
已经有20人回复
青椒一枚,请问借调到基金委对个人有用吗?
已经有37人回复
4楼2017-11-30 12:02:54
简单回复
2017-11-29 05:20
回复
harry747747(金币+1): 谢谢参与
2017-11-30 11:53
回复
harry747747(金币+1): 谢谢参与
2017-11-30 13:37
回复
harry747747(金币+1): 谢谢参与
shuwenhe6楼
2017-11-30 13:45
回复
harry747747(金币+1): 谢谢参与
1
tzynew7楼
2017-11-30 13:46
回复
harry747747(金币+1): 谢谢参与
hydzp8楼
2017-11-30 14:04
回复
李大仁爱菠萝9楼
2017-11-30 15:55
回复
harry747747(金币+1): 谢谢参与
沉默的阿呆10楼
2017-11-30 16:43
回复
harry747747(金币+1): 谢谢参与
祝福
BACKTOHO11楼
2017-11-30 17:27
回复
harry747747(金币+1): 谢谢参与
祝福
htpueab5112楼
2017-11-30 19:03
回复
harry747747(金币+1): 谢谢参与
wtazpy3913楼
2017-11-30 19:36
回复
harry747747(金币+1): 谢谢参与
稍屹6214楼
2017-11-30 20:16
回复
harry747747(金币+1): 谢谢参与
egnee1115楼
2017-11-30 20:22
回复
harry747747(金币+1): 谢谢参与
gxypbs88216楼
2017-11-30 21:00
回复
harry747747(金币+1): 谢谢参与
evuzygm51017楼
2017-11-30 21:12
回复
harry747747(金币+1): 谢谢参与
exrddwx2518楼
2017-11-30 21:48
回复
harry747747(金币+1): 谢谢参与
zrure30919楼
2017-11-30 21:54
回复
harry747747(金币+1): 谢谢参与
pkftp55120楼
2017-11-30 21:57
回复
harry747747(金币+1): 谢谢参与
祝福
词俚jc21楼
2017-11-30 22:40
回复
harry747747(金币+1): 谢谢参与










回复此楼
::
200